A retrospective study of canine and feline cutaneous vasculitis

Veterinary Dermatology

Volumn 12, Issue 5, 2001, Pages 255-264

  Nichols, Patrick R ^a   Morris, Daniel O ^b   Beale, Karin M ^c  

^a Anim Allerg Dermatol Ctr C   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Gulf Coast Veterinary Dermatology and Allergy   (United States)

Author keywords

Cat; Cutaneous vasculitis; Dapsone; Dog; Pentoxifylline; Sulfasalazine

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; FELIDAE; FELIS CATUS;

ALLERGIC VASCULITIS; ANIMAL; ANIMAL DISEASE; ARTICLE; CAT; CAT DISEASE; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; INFORMATION PROCESSING; MALE; PATHOLOGY; RETROSPECTIVE STUDY; UNITED STATES;

ANIMALS; CAT DISEASES; CATS; DOG DISEASES; DOGS; FEMALE; MALE; PENNSYLVANIA; RECORDS; RETROSPECTIVE STUDIES; VASCULITIS, ALLERGIC CUTANEOUS;

EID: 0035496573     PISSN: 09594493     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0959-4493.2001.00268.x     Document Type: Article

References (50)

1. Scott, D.W., Miller, W.H., Griffin, C.E. Small Animal Dermatology, 6th edn. Philadelphia. W.B. Saunders, 2001: 742-6.
2. Yager, J.A., Wilcock, B.P. Color Atlas and Text of Surgical Pathology of the Dog and Cat. Dermatopathology and Skin Tumors. London: Mosby-Year Book, 1994: 107-18.
3. Gross, T.L., Ihrke, P.J., Walder, E.J. Veterinary Dermatopathology - A Macroscopic and Microscopic Evaluation of Canine and Feline Skin Disease. St. Louis, MO: Mosby-Year Book, 1992: 138-40.
4. Jorizzo, J.L. Classification of vasculitis. Journal of Investigative Dermatology 1993; 100: 106S-110S.
5. Ghersetich, I., Comacchi, C., Jorizzo, J. Proposal for a working classification of cutaneous vasculitis. Clinics in Dermatology 1999; 17: 499-503.
6. Jennette, C.J., Milling, D.M., Falk, R.J. Vasculitis affecting the skin. Archives of Dermatology 1994; 130: 899-906.
7. Soter, N.A. Cutaneous necrotizing venulitis. In: Fitzpatrick, T.B., Freedberg, I.M., Eisen, A.Z. et al., eds. Dermatology in General Medicine, 5th edn. New York: McGraw-Hill, 1999: 2044-53.
8. Ghersetich, I., Comacchi, C., Katsambas, A. et al. Cellular steps in pathogenesis of cutaneous necrotizing vasculitis. Clinics in Dermatology 1999; 17: 597-601.
9. Zax, R.H., Hodge, S.J., Callen, J.P. Cutaneous leukocytoclastic vasculitis. Serial histo-pathologic evaluation demonstrates the dynamic nature of the infiltrate. Archives of Dermatology 1990; 126: 69-72.
10. Sams, W.M., Thorne, E.G., Small, P. et al. Leukocytoclastic vasculitis. Archives of Dermatology 1976; 112: 219-26.
11. Lowry, M.D., Hudson, C.F., Callen, J.P. Leukocytoclastic vasculitis caused by drug additives. Journal of the American Academy of Dermatology 1994; 30: 854-5.
12. Claudy, A.L. Pathogenesis of leukocytoclastic vasculitis. European Journal of Dermatology 1998; 8: 75-9.
13. Lunardi, C., Bambara, L.M., Biasi, D. et al. Elimination diet in the treatment of selected patients with hypersensitivity vasculitis. Clinical and Experimental Rheumatology 1992; 10: 131-5.
14. Wilcock, B.P., Yager, J.A. Focal cutaneous vasculitis and alopecia at sites of rabies vaccination in dogs. Journal of the American Veterinary Medical Association 1986; 188: 1174-7.
15. Mackel, S.E., Jordon, R.E. Leukocytoclastic vasculitis. A cutaneous expression of immune complex disease. Archives of Dermatology 1982; 118: 296-301.
16. Plotnick, A.N., Boshoven, E.W., Rosychuk, R.A.W. Primary cutaneous coccidioidomycosis and subsequent drug eruption to itraconazole in a dog. Journal of the American Animal Hospital Association 1997; 33: 139-43.
17. Legendre, A.M. Antimycotic drug therapy. In: Bonagura, J.D., ed. Kirk's Current Veterinary Therapy XII, Small Animal Practice. Philadelphia: W.B. Saunders, 1997: 327-31.
18. Witort-Serraglini, E., Del Rosso, M., Lotti, T. et al. Endothelial injury in vasculitides. Clinics in Dermatology 1999; 17: 587-90.
19. Jennette, J.C., Falk, R.J. The neutrophil and its role in systemic vasculitis. In: LeRoy, E.G., ed. The Biologic Basis of Systemic Vasculitis. New York: Marcel Dekker, 1992: 65-92.
20. Jurd, K.M., Stephens, C.J.M., Black, M.M. Endothelial cell activation in cutaneous vasculitis. Clinical and Experimental Dermatology 1996; 21: 28-32.
21. Easley, J.R. Necrotizing vasculitis: an overview. Journal of the American Animal Hospital Association 1979; 15: 207-11.
22. Manning, T.O., Scott, D.W. Cutaneous vasculitis in a dog. Journal of the American Animal Hospital Association 1980; 16: 61-7.
23. Randell, M.G., Hurvitz, A.I. Immune-mediated vasculitis in five dogs. Journal of the American Veterinary Medical Association 1983; 183: 207-11.
24. Rachofsky, M.A., Chester, O.K., Read, W.K. et al. Probable hypersensitivity vasculitis in a dog. Journal of the American Veterinary Medical Association 1989; 194: 1592-4.
25. Crawford, M.A., Foil, C.S. Vasculitis: clinical syndromes in small animals. Compendium 1989; 11: 400-15.
26. Morris, D.O., Beale, K.M. Cutaneous vasculitis and vasculopathy. Veterinary Clinics of North America: Small Animal Practice 1999; 29: 1325-35.
27. Claudy, A.L. Diagnosis of cutaneous vasculitis. International Angiology 1994; 14: 183-7.
28. Stevens, G.L., Adelman, H.M., Wallach, P.M. Palpable purpura: an algorithmic approach. American Family Physician 1995; 52: 1355-62.
29. Parillo, J.E., Fauci, A.S. Mechanisms of glucocorticoid action on immune processes. Annual Review of Pharmacology and Toxicology 1979; 19: 179-201.
30. MacGregor, R.R. Granulocyte adherence changes induced by haemodialysis, endotoxin, epinephrine and glucocorticoids. Annals of Internal Medicine 1977; 86: 35-9.
31. Atzori, L., Ferreli, C., Biggio, P. Less common treatment in cutaneous vasculitis. Clinics in Dermatology 1999; 17: 641-7.
32. Fadok, V.A., Barrie, J. Sulfasalazine responsive vasculitis in the dog: a case report. Journal of the American Animal Hospital Association 1982; 20: 161-7.
33. Fredenberg, M.F, Malkinson, F.D. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Journal of the American Academy of Dermatology 1987; 16: 772-8.
34. Debol, S.M., Herren, M.J., Nelson, R.D. Antiinflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction. Journal of Leukocyte Biology 1997; 62: 827-36.
35. Wozel, G., Barth, J. Current aspects of modes of action of dapsone. International Journal of Dermatology 1998; 27: 547-52.
36. Samlaska, C.P., Winfield, E.A. Pentoxifylline. Journal of the American Academy of Dermatology 1994; 30: 603-21.
37. Bruynzeel, I., Stoof, T.J., Willemze, R. Pentoxifylline and skin inflammation. Clinical and Experimental Dermatology 1998; 23: 168-12.
38. Ely, H. Is pentoxifylline the drug of the decade? Journal of the American Academy of Dermatology 1994; 30: 639-42.
39. Vena, G.A., Cassano, N. Immunosuppressive therapy in cutaneous vasculitis. Clinics in Dermatology 1999; 17: 633-40.
40. Sais, G., Vidaller, A., Jucgla, A. et al. Colchicine in the treatment of cutaneous Ieukocytoclastic vasculitis. Archives of Dermatology 1995; 131: 1399-402.
41. Marsella, R., Nicklin, C.F., Munson, J.W. et al. Pharmacokinetics of pentoxifylline in dogs after oral and intravenous administration. American Journal of Veterinary Research 2000; 61: 631-7.
42. Parker, W.M., Foster, R.A. Cutaneous vasculitis in five Jack Russell terriers. Veterinary Dermatology 1996; 7: 109-15.
43. Vitale, C.B., Gross, T.L., Magro, C.M. Vaccine-induced ischemic dermatopathy in the dog. Veterinary Dermatology 1999; 10: 131-42.
44. Venzor, J., Baer, S.C., Huston, D.P. Urticarial vasculitis. In: Charlesworth, E.N., ed. Immunology and Allergy Clinics of North America. Philadelphia: W.B. Saunders, 1995: 761-74.
45. Black, A.K. Urticarial vasculitis. Clinics in Dermatology 1999; 17: 565-9.
46. Veien, N.K., Krogdahl, A. Cutaneous vasculitis induced by food additives. Acta Dermato-Venereologica (Stockholm) 1990; 71: 73-4.
47. Scott, D.W., MacDonald, J.M., Schultz, R.D. Staphylococcal hypersensitivity in the dog. Journal of the American Animal Hospital Association 1978; 14: 766-79.
48. Comacchi, C, Ghersetich, I., Katsambas, A. et al. γ/δ Tlymphocytes and infection: pathogenesis leukocytoclastic cutaneous necrotizing vasculitis. Clinics in Dermatology 1999; 17: 603-7.
49. Cribier, B., Couilliet, D., Meyer, P. et al. The severity of histopathological changes of leukocytoclastic vasculitis is not predictive of extracutaneous involvement. American Journal of Dermatopathology 1999; 21: 532-6.
50. Griem, P., Wulferink, M., Bernhardt, S. et al. Allergic and autoimmune reactions to xenobiotics: how do they arise? Immunology Today 1998; 19: 133-41.